Karen S. Lovitch
(she/her/hers)
Chair, Health Law Practice & Co-Chair, Health Care Enforcement Defense Practice
+1.202.434.7324
Karen draws from her deep health care regulatory knowledge to provide legal and practical business counsel to clients across the health care and life sciences industries. Recognized by a client in Chambers USA as an “absolute star attorney in the area of health care compliance,” Karen applies this foundation when representing clients in state and federal government investigations, transactions, and day to day regulatory and operational matters. She is highly regarded for her commitment to exceptional client service and her unique ability to guide clients through the complex maze of regulatory and business issues, providing holistic guidance on both to in-house counsel. Karen is Chair of the firm’s Health Law Practice and Health Care Enforcement Defense Practice. She is a member of the firm’s Executive Committee
Karen’s substantial health care regulatory and compliance background includes advising clients on matters pertaining to the federal anti-kickback statute, the Stark law, the Eliminating Kickbacks in Recovery Act (EKRA), state statutes prohibiting kickbacks and self-referrals, Medicare and Medicaid program an reimbursement requirements, the Clinical Laboratory Improvement Amendments of 1988 (CLIA), the federal Physician Payments Sunshine Act, and state licensure laws. She also has experience advising clients operating in the value-based care arena. Karen routinely works with clients to develop and implement health care compliance programs to avoid the government spotlight, oversees internal investigations, and advises clients on the legal, practical, and fraud and abuse implications of business arrangements and sales and marketing practices.
In addition to counseling health care and life sciences entities on regulatory matters, Karen represents clients subject to federal False Claims Act investigations and qui tam litigation, state investigations involving false claims/insurance fraud, state and federal surveys and inspections, and state licensure proceedings. She has negotiated and structured high stakes settlement agreements with the US Department of Justice and its US Attorneys’ Offices and state Attorneys General Offices, as well as corporate integrity agreements with the Department of Health and Human Services Office of Inspector General. In the negotiation of a recent significant settlement on behalf of a client with several US Attorneys’ Offices and the Department of Justice, Karen successfully negotiated no admission of liability and no corporate integrity agreement.
Karen draws upon her regulatory counseling and health care enforcement experience to provide practical advice on health care regulatory transactions, including the assessment of risk, appropriately tailored reps and warranties, and the negotiation of R&W insurance exclusions. Karen serves as regulatory counsel to private equity firms, other investors, and health care companies in mergers, acquisitions, and other transactional matters. She leads complex due diligence projects for these entities across a vast array of industry areas, including behavioral health, laboratories, diagnostic companies, hospice and home health providers, and benefit management companies.
Karen also specializes in the representation of laboratories and diagnostics companies. She regularly counsels on compliance with CLIA and state laboratory licensure laws, federal and state limitations on billing for diagnostic services, and legal restrictions on sales and marketing activities. Karen has served as regulatory counsel in a number of mergers and acquisitions involving laboratories and diagnostics companies and has represented numerous laboratories and diagnostics companies in state and federal government investigations.
She is a frequent author and speaker on regulatory and compliance issues confronting the industry and editor of the firm’s Health Care Viewpoints.
Karen has two German Shepherds, and she has served as a foster parent for the Mid-Atlantic German Shepherd Rescue for many years. She and her family have helped nearly 30 dogs find their forever homes.
Karen is great at taking something incredibly complex and simplifying it. She is always calm and collected.
-Healthcare Client, Chambers USA 2025
Experience
Transactions
- Served as health care regulatory to TPG Capital in its majority investment in Surescripts, the nation’s leading health information network.
- Served as health care regulatory counsel to TPG Capital in its acquisition of One Oncology, along with its co-investor, Cencora.
- Advised TPG Growth on health care regulatory issues associated with its acquisition of a majority stake in Crowe LLP’s health care consulting unit, which was rebranded as Kodiak Solutions.
- Served as health care regulatory counsel to TPG Capital in its new partnership with existing investors, Summit Partners and Silversmith Capital Partners, to back outpatient behavioral health services provider, LifeStance Health.
- Served as health care regulatory counsel to Kindred Healthcare, a specialty hospital company focused on acute care, and private equity firm TPG Capital in the sale of Kindred Healthcare to national health services provider LifePoint Health, launching the combined company ScionHealth.
- Advised a consortium of investors led by TPG Capital and Welsh, Carson, Anderson & Stowe in their $4.1 billion acquisition of Kindred Healthcare, Inc. (NYSE:KND) and their $1.4 billion acquisition of Curo Health Services. The Kindred Healthcare transaction was recognized by The Deal as the 2018 Private Equity Deal of the Year.
- Provided health care regulatory advice to Myriad Genetics, a Nasdaq-listed molecular diagnostics company, in its acquisition of Assurex Health, an informatics-based precision medicine company.
- Served as health care regulatory counsel to Fulgent Genetics, in its acquisition of CSI Laboratories.
Investigations
- Represented a national pathology laboratory in its False Claims Act self-disclosure made to the Boston U.S. Attorney’s Office, which resulted in a monetary settlement far below the potential damages amount.
- Conducted an internal investigation for a statewide hospital system related to a Medicare Part A issue, advised on repayment and disclosure options, and prepared the overpayment return submission to the Medicare Administrative Contractor.
- Convinced the Seattle U.S. Attorney’s Office to decline to intervene in a qui tam case involving risk-adjustment related allegations made against an accountable care organization support company. We are defending the company in a follow-on False Claims Act retaliation case brought by the former employee relator, who has dismissed all other False Claims Act claims.
- Represented a national health care company in a government investigation conducted by the Delaware U.S. Attorney’s Office that initially involved a damages claim for tens of millions of dollars, but which ultimately resulted in a settlement of just over $700,000.
- Convinced the U.S. Attorney’s Office for the Middle District of Florida to decline a qui tam case brought against a national health care provider. After winning on a motion to dismiss three times, the litigation team won the case on appeal to the Third Circuit Court of Appeals.
- Represented a national health care insurer in its response to an Office of Inspector General subpoena focused on its relationship with a particular pharmaceutical manufacturer.
- Negotiated the settlement of a five-year False Claims Act investigation conducted by multiple U.S. Attorney’s Offices and DOJ’s Civil Division on behalf of a national health care provider. We successfully convinced the Office of Inspector General for the Department of Health and Human Services not to pursue a Corporate Integrity Agreement.
- Represented a national health care provider in a False Claims Act investigation conducted by the U.S. Attorney’s Office for the Southern District of New York. The government ultimately declined to intervene, and the relator chose to voluntarily dismiss the case.
- Counseled a specialty laboratory regarding whether and how to make a self-disclosure related to a Medicare overpayment and met with the U.S. Attorney’s Office regarding the self-disclosure, which did not lead to further investigation or enforcement action.
- Represented a national health care provider in a False Claims Act investigation conducted by the U.S. Attorney’s Office for the Northern District of Ohio. Following the government’s declination, the court dismissed the case upon the provider’s motion and refused to allow the relator to amend his complaint a second time.
viewpoints
California Governor Vetoes Private Equity and Hedge Fund Health Care Transaction Review Law (AB-3129)
October 1, 2024 | Blog | By Daniel Cody, Kathryn Edgerton, Karen Lovitch
On September 28, 2024, California Governor Gavin Newsom vetoed California Assembly Bill 3129 (AB-3129) originally introduced by California Attorney General Rob Bonta (AG) and Assembly Speaker pro Tempore Jim Wood and passed by the California legislature earlier in the month. While the California legislature can override the Governor’s veto, legislators likely will not take this extraordinary step, which has not been taken in several decades.
DOJ Issues its Highly Anticipated Whistleblower Awards Pilot Program
August 15, 2024 | Blog | By Eoin Beirne, Karen Lovitch, Brian Dunphy, Nick A. LaPalme
In March 2024, at the American Bar Association’s 39th National Institute on White Collar Crime, Deputy Attorney General (“DAG”) Lisa Monaco announced that the Department of Justice (“DOJ” or the “Department”) intended to create a new whistleblower rewards pilot program.
A Mintz Health Care Roundtable: Current Trends in State Health Care Transaction Review and What to Expect in 2024
March 27, 2024 | Blog | By Stephnie John, Daniel Cody, Deborah Daccord, Karen Lovitch
States are increasingly exercising regulatory oversight of health care transactions by enacting laws requiring prior notice or approval of certain health care transactions. Currently, 15 states have enacted health care transaction review laws applicable to for-profit transactions. On Wednesday, March 20, 2024, Mintz members Daniel A. Cody, Deborah A. Daccord, and Karen S. Lovitch engaged in an insightful discussion with Lois Johnson, General Counsel of Massachusetts Health Policy Commission, to discuss the latest developments surrounding these laws and gain valuable insight from Ms. Johnson’s expertise, as Massachusetts was one of the first states to implement a health care transaction review process. The highlights of this informative conversation are summarized below, and the webinar can be viewed here.
DOJ Announces it is Designing a Whistleblower Rewards Program
March 18, 2024 | Blog | By Eoin Beirne, Karen Lovitch, Brian Dunphy, Nick A. LaPalme
In early March 2024 at the American Bar Association’s 39th National Institute on White Collar Crime, Deputy Attorney General (DAG) Lisa Monaco’s keynote remarks previewed the development of new and significant Department of Justice (DOJ or the Department) policy initiatives. Her speech reemphasized many of DOJ’s key themes throughout the current administration, including individual accountability, the importance of strong corporate compliance programs, incentivizing voluntary self-disclosure of misconduct, and adapting to keep up with disruptive technologies such as artificial intelligence.
FTC Hosts Panel and Launches Public Inquiry with DOJ and HHS on Private Equity and Health Care
March 6, 2024 | Advisory | By Karen Lovitch, Bruce Sokler, Joseph Miller, Raj Gambhir
Read about the FTC’s March 5, 2024 workshop on private equity (PE) investments in the health care industry and a joint request for information on the effects of PE transactions in the health care industry issued by the FTC, DOJ, and HHS.
California Bill (AB-3129) Targets Private Equity and Hedge Fund Health Care Transactions
March 1, 2024 | Blog | By Kathryn Edgerton, Deborah Daccord, Karen Lovitch
California Attorney General Rob Bonta (AG) and Assembly Speaker pro Tempore Jim Wood recently introduced legislation (AB-3129) that would authorize the AG to review private equity group and hedge fund health care transactions. The proposed legislation’s stated intention is to address price increases and lower quality of and decreased accessibility to services associated with private equity acquisitions of certain health care entities, including physician practices. This article provides an overview of the proposed bill, an analysis of the key issues raised by the proposed legislation, and suggestions for next steps for those potentially affected by the proposal.
California’s Health Care Transactions Review Law: Preparing for What Comes Next
February 26, 2024 | Blog | By Kathryn Edgerton, Deborah Daccord, Karen Lovitch
California’s health omnibus trailer bill SB-184 and the final cost and market impact review (CMIR) regulations (CMIR Regulations), which went into effect on December 18, 2023, have ushered in a significant change in California’s health care regulatory landscape with the creation of the Office of Health Care Affordability (OHCA). On January 2, 2024, OHCA began accepting notices of covered transactions through its notice of material change transaction submission portal.
Safeguarding Reproductive Rights
February 23, 2024 | Article
Lawyers for Good Government, in partnership with the American College of Obstetricians and Gynecologists, initiated a vital project known as The Policy Resource Hub in 2022.
EnforceMintz — Despite Few Enforcement Actions in 2023, PE Investment in Health Care Remains a Hot Topic
February 8, 2024 | Blog | By Grady Campion, Karen Lovitch
After growing significantly over the last decade, private equity health care deal activity nevertheless remained robust last year, with an estimated deal volume of about $29 billion in North America.
News & Press
Mintz has earned top rankings in the 2025 edition of Legal 500 United States and Canada guides. The firm is recognized in 20 practice categories, and 78 of its attorneys are individually ranked in the guide, with several receiving recognition in more than one category. Additionally, two attorneys are featured in the "Hall of Fame," seven attorneys are named "Leading Lawyers," and five attorneys are recognized as a "Next Generation Lawyers."
Chambers USA has recognized 43 of Mintz’s practices and 88 of its attorneys in its 2025 guide to the country’s leading law firms. Of those featured in the guide, 17 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm expanded its rankings this year with three new practice area listings and 17 attorneys recognized for the first time or in additional categories.
The Pros and Cons of Self-Disclosure: Q&A With Karen Lovitch
March 14, 2025
Health Care and Health Law Practice Chair Karen Lovitch was featured in a Q&A by Laboratory Economics about the pros and cons of companies and clinical labs self-disclosing potential civil and criminal violations.
JD Supra has recognized ten Mintz attorneys in its 2025 Readers’ Choice Awards. The awards recognize attorneys and firms whose articles on the JD Supra platform were most read by C-suite executives, in-house counsel, media, and other professionals during 2024.
Healthcare’s AI Deal Advantage
October 21, 2024
Health Law Practice Chair Karen Lovitch recently spoke with Mergers & Acquisitions about some of the different ways AI is transforming the healthcare industry and how PE firms and strategic buyers are viewing the space advantageously.
Mintz Advises TPG in Strategic Partnership with Surescripts
October 04, 2024
Mintz advised global alternative asset management firm TPG in a strategic partnership with Surescripts®, the nation’s leading health information network. The partnership includes an investment in Surescripts through TPG Capital, the firm’s U.S. and European private equity platform.
Special Report: The 2024 Lab Enforcement Landscape
August 29, 2024
Health Law Practice Chair Karen Lovitch and Of Counsel Samantha Kingsbury were quoted in a G2 Intelligence special report about the 2024 lab enforcement landscape.
The Best Lawyers in America 2025 Recognizes 184 Mintz Attorneys across 56 Practice Areas
August 15, 2024
187 Mintz attorneys have been recognized by Best Lawyers® in the 2025 edition of The Best Lawyers in America©. Notably, three Mintz attorneys received 2025 “Lawyer of the Year” awards, and 64 firm attorneys were included in the 2025 edition of Best Lawyers: Ones to Watch.
Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.
Health Law Chair and Health Care Enforcement Defense Co-chair Karen Lovitch spoke with Laboratory Economics offering insight on two recent cases where the former owner of a Missouri healthcare company, Genotec DX, and clinical laboratory, Advanced Geriatric Management LLC (AGM), and a compliance officer face prison time over fraudulent claims. The former owner admitted to submitting more than $3.8 million in false claims to Medicare, Medicaid, and private healthcare benefit programs.
Mintz Adds Fire Power to Leading Health Law Practice with New Member
December 04, 2023
WASHINGTON, DC – Mintz has deepened its health care bench with the addition of new Member, Rachel Alexander.
Settlement Highlights Benefits of Self-Disclosure
July 5, 2023
Mintz Member Karen Lovitch, Chair of the firm’s Health Law Practice and Co-Chair of the Health Care Enforcement Defense Practice, was interviewed for an article included in the July 2023 issue of Laboratory Economics. Commenting on a recent settlement by a company providing billing services for clinical laboratories, Karen highlights the benefits of self-disclosure when noncompliance is discovered.
BOSTON – Mintz has earned top rankings in the 2023 edition of Legal 500 United States guide. The firm is recognized in 14 practice categories, and 59 individual attorneys are also recognized in the guide, some in more than one category.
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
Mintz Member Karen Lovitch, Chair of the firm’s Health Law Practice and Co-Chair of the Health Care Enforcement Defense Practice, was interviewed for an article included in the May 2023 issue of Laboratory Economics, concerning the federal government's continued focus on Covid-19 fraud and recent criminal charges brought by the Department of Justice.
WASHINGTON, DC – Mintz is pleased to announce the inclusion of five Members to the 2023 Washington, D.C. Super Lawyers list.
Mintz Forms Pioneering Women’s Health & Technology Practice
March 09, 2023
Mintz’s new Women’s Health and Technology Practice brings together attorneys from our transactional, intellectual property, health care, FDA regulatory, and litigation teams to serve FemTech and other life sciences clients. The practice advises companies, entrepreneurs, and investors focused on addressing unmet needs in women’s health.
Mintz Debuts 'Femtech' Practice For Life Science Clients
March 9, 2023
Law360 featured the launch of the firm's Women's Health and Technology practice and highlighted founding Members Ellen Janos, Joanne Hawana, Karen Lovitch, and Melanie Levy.
Mintz Member and Chair of the firm’s Health Law and Health Care Enforcement Defense Practices Karen Lovitch was interviewed for an article included in the January 2023 issue of Laboratory Economics covering the top compliance challenges faced by clinical laboratories, Covid-19 testing fraud, and more.
Mintz Appoints New Health Care And Enforcement Defense Leadership
January 18, 2023
BOSTON – Mintz has appointed Brian Dunphy as Co-Chair of the firm’s Health Care Enforcement Defense Group with immediate effect. Brian joins Karen Lovitch, who also serves as Chair of the Health Law Practice, in joint leadership.
Best Lawyers® recognized 108 firm attorneys in the 2023 edition of The Best Lawyers in America©. Notably, two Mintz attorneys – Poonam Patidar and Scott M. Stanton – received 2023 “Lawyer of the Year” awards, and 28 firm attorneys were included in the inaugural edition of Best Lawyers: Ones to Watch.
DOJ Crackdown on Genetic Testing Telefraud
August 15, 2022
Mintz Advises Kindred Healthcare in Sale to LifePoint Health, Launching ScionHealth
December 23, 2021
Healthcare Enforcement & Litigation 2022
August 27, 2021
How New Kickback Rules Benefit Health Care Industry: Part 1
December 18, 2020
How New Kickback Rules Benefit Health Care Industry: Part 2
December 18, 2020
CMS Publishes Proposed 2021 Medicare Physician Fee Schedule
August 24, 2020
Mintz Practice Groups and Attorneys Garner Top Rankings in 2020 Edition of The Legal 500 United States
June 12, 2020
TPG Invests in Behavioral Health Firm LifeStance
April 20, 2020
2019 Trends In DOJ Civil Health Care Fraud Cases
January 15, 2020
Hospitals’ Risk May Rise as Anti-Fraud Proposal Narrows Loophole
October 25, 2019
Mintz Recognized by Chambers USA 2019
April 26, 2019
Antiopioid Law Could Criminalize Sales Commissions for Clinical Lab Patient Referrals
April 18, 2019
AHLA Health Care Compliance Legal Issues Manual
March 5, 2019
Chambers USA 2018 Ranks Mintz Attorneys & Practices
May 03, 2018
Private Equity FCA Suit More Likely Outlier Than Omen
March 16, 2018
Laboratory Economics' PAMA Teleconference Highlights
February 19, 2018
2017 Health Care Enforcement Review: Final Thoughts
January 19, 2018
Labs Wage Legal Fights Over Fees, Medical Necessity Checks
November 14, 2017
Leader of Mintz Health Law Practice Karen Lovitch to Speak at 2017 G2 Intelligence Lab Institute Conference
October 11, 2017
Mintz’s Health Law Practice Recognized Among Industry Leaders in Annual BTI Power Rankings
August 17, 2017
New Safe Harbor Allows Labs to Provide Patient Transport
February 28, 2017
Health Care Enforcement Review And 2017 Outlook: Part 4
January 19, 2017
Health Care Enforcement Review And 2017 Outlook: Part 3
January 18, 2017
Health Care Enforcement Review And 2017 Outlook: Part 2
January 17, 2017
Lab Institute 2016 Recap
November 8, 2016
Lesson from RML's $1.1 Million Settlement: Beware of Carve-Outs and Pull-Through Arrangements
October 18, 2016
Mintz Represents Myriad Genetics in Acquisition of Assurex Health
September 08, 2016
CMS finalizes lab fee schedule changes: 5 key takeaways
June 21, 2016
What Is The Anti-Kickback Statute?
January 1, 2015
podcasts
Health Law Diagnosed – New Year's Gratitude
February 3, 2025 | Podcast | By Bridgette Keller, Alison H. Peters, Samantha Kingsbury, Theresa Carnegie, Joanne Hawana, Abdie Santiago, Stephnie John, Pamela Polevoy, Karen Lovitch, Jean D. Mancheno, Deborah Daccord, Rachel A. Alexander, Jane Haviland, David Gilboa, Kathryn Edgerton, Hassan Shaikh, Madison Castle, Laurence Freedman, Priyanka Amirneni, Samantha Hawkins, Tara E. Dwyer, Rachel Yount, Sophia Temis, Xavier Hardy
Host Of Counsel Bridgette Keller invites the Mintz Health Law team to reflect on what they’re grateful for as they prepare for the year ahead. Hear from a dynamic group of Members, Of Counsel, and Associates as they share their perspectives on what’s coming up over the horizon.
Health Law Diagnosed — Mintz Health Law Team: Reflecting on What We Are Grateful For
February 5, 2024 | Podcast | By Bridgette Keller
As the Mintz Health Law team welcomes the beginning of 2024, many of its members take a moment to reflect on the exciting growth of the Health Law Practice, opportunities to partner with clients on complex legal issues, and the celebration of numerous milestones.
Health Law Diagnosed – EnforceMintz – Part 2: DOJ Regulatory and Policy Update
April 25, 2023 | Podcast | By Bridgette Keller, Eoin Beirne, Karen Lovitch, Brian Dunphy
In this episode, Health Care Enforcement Defense specialists Eoin Beirne, Karen Lovitch, and Brian Dunphy discuss key regulatory and policy updates issued by the DOJ and their potential impact on False Claims Act cases, from self-disclosure to privacy regulations.
Health Law Diagnosed – EnforceMintz: Analyzing Health Care False Claims Act Cases
April 18, 2023 | Podcast | By Bridgette Keller, Karen Lovitch, Brian Dunphy, Eoin Beirne
Bridgette Keller speaks with Karen Lovitch, Brian Dunphy, and Eoin Beirne about the Mintz Health Care Enforcement Defense Practice’s recent edition of the EnforceMintz newsletter, Analyzing Health Care False Claims Act Cases, and key health care enforcement trends.
Mintz Health Law: What We Are Grateful For
January 11, 2023 | Podcast | By Bridgette Keller
Bridgette Keller speaks with the Mintz Health Law team about what they are grateful for as they look back on a year of client service, mentorship, and working together as a team.
Health Law Diagnosed — Mintz’s 2022 Health Law New Year’s Resolutions
January 12, 2022 | Podcast | By Bridgette Keller
Health Law Diagnosed — Final Rules Amending the Anti-Kickback Statute and Stark Law Regulations: Part 2
March 17, 2021 | Podcast | By Karen Lovitch, Rachel Yount
Health Law Diagnosed — Final Rules Amending the Anti-Kickback Statute and Stark Law Regulations: Part 1
February 16, 2021 | Podcast | By Karen Lovitch, Rachel Yount
Events & Speaking
Important Developments in Laboratory Legal, Regulatory, and Compliance Requirements
29th Annual Executive War College on Laboratory and Pathology Management
New Orleans, Louisiana
CMS Final Rule Targeting Private Equity and REIT Ownership of Nursing Facilities
Strafford Webinars
Virtual
Health Care Fraud Enforcement Developments and Whistleblower Avoidance
G2 Lab Institute: Advancing the Profession of Diagnostic Medicine
Virtual Event
Can We Do This? Avoiding Marketing and Business Development Compliance Pitfalls
REDC Member Meeting
InterContinental Minneapolis
Telehealth Regulation & Enforcement: 2021 Year in Review & 2022 Outlook
Mintz & ML Strategies
Online Event
Reducing Patient Leakage by Directing Physician Referrals, AKS Safe Harbors, and Stark Law Exceptions
Strafford
Online Event
HHS’s Holiday Gift to the Health Care Industry: Historic Changes to the Anti-Kickback Statute and Stark Law Regulations
View the Webinar Recording
Received COVID-19 Funding? How to Mitigate and Respond to Enforcement Risks and Government Actions
View the Webinar Recording
Executive War College on Lab and Pathology Management
Current Issues in Clinical Lab and Pathology Law, Compliance, Managed Care Contracting, and More
Sheraton New Orleans
Laboratory & Pathology Management
Executive War College
Sheraton New Orleans 500 Canal St. New Orleans, LA 70130
American Clinical Laboratory Association 2018 Annual Meeting
American Clinical Laboratory Association
Washington, DC
Medicare's Market-Based Payment Startup: Strategic Options & Compliance Red Flags for Labs
Laboratory Economics
Webinar
Trends in Enforcement and Regulatory Guidance - What Should be on Your AKS Radar?
The American Bar Association
Webinar
Hot Topics in Laboratory Compliance
American Health Lawyers Association
Hilton Baltimore Hotel, Baltimore, MD
Publications
- Co-author, What Is...The Anti-Kickback Statute?, Second Edition, Published by the American Bar Association (2022)
- Co-author, Crackdown on COVID-19 Testing Fraud Continues, Published by G2 Intelligence (2024)
Recognition & Awards
Included on the Washington DC Super Lawyers: Health Care list (2017 – 2024)
Best Lawyers in America: Health Care Law (2021 – 2025)
Chambers USA: District of Columbia – Healthcare (2014 – 2025)
Recognized by The Legal 500 United States for Healthcare: Service Providers (2014 – 2025)
Involvement
- The Women Business Leaders of the U.S. Health Care Industry Foundation
- Board Member (2019 - 2022), Advisory Board Member (2022 - Present), DC KinCare Alliance
- Board Member, DC SCORES (2013 – 2016)
- Board Member, Suited for Change (2007 – 2010)
- Foster Parent, Mid-Atlantic German Shepherd Rescue
Recent Insights
Karen S. Lovitch
(she/her/hers)